If pain seems to come from a muscle, tendon, or joint rather than the skin, near-infrared light is usually the more logical wavelength to prioritize. It generally travels farther through tissue than visible red light. But “deeper” does not mean “stronger,” and penetration alone does not prove better pain relief.
The practical answer is this: choose a device with meaningful near-infrared output for a deep musculoskeletal target, consider a red-plus-near-infrared device when you also want superficial coverage, and judge the treatment by the specific condition, device instructions, and clinical evidence—not by wavelength marketing alone.
Red light and near-infrared light: the useful difference
Both are forms of non-ionizing light used in photobiomodulation (PBM), sometimes called low-level light therapy. The key distinction is where the light is likely to be absorbed before its intensity falls substantially.
- Red light is visible and commonly falls roughly in the 600–700 nanometer range. It is better suited to superficial targets such as the skin and tissues close to the surface.
- Near-infrared (NIR) light is invisible and commonly falls roughly in the 780–950 nanometer range in PBM research. Longer wavelengths generally penetrate farther, making NIR a more plausible choice when the intended target is beneath skin and subcutaneous tissue.
A review of PBM parameters describes red wavelengths as primarily superficial and longer near-infrared wavelengths as preferable for deeper tissues. That is a general optical principle, not a guarantee that every NIR device reaches a particular joint or muscle at a therapeutically useful dose. Tissue thickness, pigmentation, fat, blood, the device’s irradiance, treatment distance, and exposure time all affect what arrives at the target.
Is near-infrared better for deep muscle and joint pain?
Often, as a targeting choice—but not automatically as a treatment.
If the goal is to deliver light beyond the skin, NIR has the clearer rationale because it tends to penetrate more deeply. That can make it a sensible emphasis for a large muscle, a tendon beneath thicker tissue, or a joint area. Red light may still contribute at the surface, but less of it is expected to reach deeper structures.
However, three distinctions prevent an overconfident conclusion:
- Penetration is not the same as clinical effectiveness. A wavelength can reach farther without producing a meaningful change in pain or function.
- A joint is not a single target. Pain around a knee, shoulder, or hip may involve skin, muscle, tendon, ligament, joint capsule, nerve, or several structures. The cause matters more than the label “joint pain.”
- PBM is dose-dependent. Wavelength works alongside irradiance, energy delivered, contact or distance, treatment area, and schedule. More light is not necessarily better, and research protocols vary widely.
For that reason, the most defensible claim is “NIR is generally better matched to deeper targets,” not “NIR is proven superior for all deep pain.”
What does the pain research actually show?
Research on PBM is promising but uneven. Clinical studies and reviews have examined musculoskeletal pain, tendinopathy, osteoarthritis, sports injuries, and chronic pain using both red and near-infrared wavelengths. Results differ because studies use different devices, doses, treatment schedules, diagnoses, and comparison groups.
A systematic review and meta-analysis of red and near-infrared PBM for tendinopathy evaluated randomized trials rather than assuming that one wavelength works for every tendon problem. Reviews of infrared treatment for musculoskeletal conditions have also reported reductions in pain, but that does not establish a single best wavelength or protocol for home use.
A newer systematic review of randomized clinical trials in chronic pain highlights the same limitation: PBM studies commonly use red and NIR wavelengths, yet protocols and outcomes vary considerably. This makes it difficult to translate a study’s result directly to a consumer device.
PBM is thought to influence cellular and inflammatory signaling, but proposed mechanisms do not equal a guaranteed outcome. Treat the evidence as support for a possible adjunct—not as proof that light will resolve the source of pain or replace exercise therapy, rehabilitation, medication, or medical evaluation when those are appropriate.
When red light may still be the better fit
NIR is not the right answer simply because pain is present. Red light can be reasonable when:
- the target is close to the surface;
- you are treating skin or a superficial wound under appropriate professional guidance;
- the device provides red light at a useful output but little or no NIR;
- you want broad red-plus-NIR coverage rather than a single wavelength;
- the treatment area is thin enough that superficial delivery is relevant.
A combined device can be practical because it covers more than one tissue depth. But “combined” is not automatically better: check whether the device clearly states its wavelengths and how to use each mode, rather than assuming that more colors or LEDs mean a more effective treatment.
How to choose for a muscle or joint problem
Use this checklist before comparing brands or counting LEDs.
1. Identify the target and the diagnosis
“Deep muscle pain” may be delayed soreness, a strain, referred pain, or something else. “Joint pain” may reflect osteoarthritis, bursitis, tendon irritation, injury, or an inflammatory condition. If pain is new, severe, worsening, associated with swelling or fever, follows significant trauma, or causes weakness or loss of function, seek medical assessment instead of using light to mask it.
The American Society for Laser Medicine and Surgery’s public guidance, as summarized in this safety discussion, emphasizes that the cause of pain should be evaluated before PBM. That is especially important because temporary symptom relief could delay attention to a fracture, infection, or other condition.
2. Prioritize NIR for a genuinely deep target
Look for transparent wavelength information rather than the vague phrase “infrared.” NIR in the broad 780–950 nm research range is not one identical treatment, and a device’s wavelength does not reveal how much energy reaches your tissue. If the target is superficial, red may be sufficient; if it is deeper, NIR deserves priority.
3. Check treatment distance and output instructions
A panel used several inches away does not deliver the same dose as a small applicator touching the skin. Compare the manufacturer’s stated distance, irradiance, exposure time, and treatment area. Do not copy a protocol from a study unless the device and dose are genuinely comparable.
4. Prefer a repeatable routine over maximum intensity
Follow the device instructions and change one variable at a time. If the skin becomes uncomfortable, unusually hot, irritated, or dry, stop and reassess. Avoid extending sessions simply because you cannot feel the light working; PBM is not judged by heat or an immediate sensation.
5. Measure function as well as pain
Keep a simple record of pain, mobility, sleep, and the activity that triggers symptoms. If there is no meaningful improvement after a reasonable trial consistent with the device guidance, reconsider the diagnosis, placement, dose, and whether another treatment is needed. Light should support—not displace—proven rehabilitation and load management where indicated.
Safety points that deserve attention
Use eye protection if the device instructions call for it, and do not stare into bright LEDs or aim them at the eyes. Be cautious if you take medication that increases light sensitivity, have a photosensitive condition, have an active cancerous lesion in the treatment area, are pregnant, or are treating a child. Evidence and product guidance differ across these situations, so ask a qualified clinician before use.
Do not use PBM over an unexplained lump, an acutely injured area, or a suspected infection as a substitute for assessment. Also remember that LED PBM and laser-based treatments are not interchangeable: their delivery characteristics and safety instructions can differ.
Bottom line
Near-infrared light is generally the better wavelength match for pain that appears to involve deeper muscle, tendon, or joint tissue because it penetrates farther than red light. It is not automatically the better treatment, because outcomes depend on the diagnosis, dose, device delivery, and the quality of evidence for that condition.
Choose transparent specifications, follow the instructions, track function—not just sensations—and treat light therapy as a possible adjunct. If you do not know why the area hurts, get that question answered before trying to treat it with either red or near-infrared light.
Small
Moderate
Moderate
Moderate
Full
